Doctors are turning to a groundbreaking new therapy; one that’s not only giving patients more healthy years, but in some ...

In this video, Leo I. Gordon, MD, FACP, discusses the growing view that follicular lymphoma could be viewed as “curable.” ...

A 13-year-old boy who was initially told that a lump in his neck was due to tonsillitis was later diagnosed with stage 4 ...

Dupixent (dupilumab) has been a breakthrough treatment for people with severe eczema, asthma, and other inflammatory ...

Receiving a diagnosis of stage 2 Lymphoma is a major life event, and it's perfectly normal to feel a mix of emotions. This ...

We evaluated disease and treatment characteristics of patients with relapse after risk-adapted first-line treatment of early-stage, favorable, classic Hodgkin lymphoma (ES-HL). We compared second-line ...

Please provide your email address to receive an email when new articles are posted on . Patients with early-stage classic Hodgkin lymphoma and other neoplasms exhibited higher risk for cardiovascular ...

The Food and Drug Administration (FDA) has approved Adcetris ® (brentuximab vedotin) for the treatment of pediatric patients 2 years and older with previously untreated high risk classical Hodgkin ...

CINCINNATI (WKRC) -A new report is now raising concerns about tattoos and a possible connection to cancer. Now oncologists are sharing what they want those with tattoos to know about their potential ...

The integration of Bruton tyrosine kinase (BTK) inhibitors into first-line treatment regimens, in combination with ...

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+ B-Cell Non-Hodgkin's Lymphoma PURPOSE: Classical Hodgkin's disease and non-Hodgkin's B-cell lymphoma ...